McKnight's Long-Term Care News2d
RSV vaccine had high efficacy in older adults in first two seasons: study
The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.
ETF Daily News15d
Pfizer (NYSE:PFE) Shares Up 2.9% on Earnings Beat
Pfizer Inc. (NYSE:PFE – Get Free Report ... infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 ...
Yahoo Finance15d
GSK, Pfizer sales of RSV shots slow as vaccination rates ebb
Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized ... In a earnings report Tuesday, Pfizer said sales of its vaccine Abrysvo fell 62% year over year ...
Sydney Morning Herald15d
Pregnant women now able to get RSV vaccine for free
Add videos to your saved list and come back to them any time.
USA Today15d
Is a 'quademic' swirling? What you should know about flu, RSV, COVID and norovirus
A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...